Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella Sativa Seed Extract in Elderly Hypertension
NCT01393054Phase 3Unknown
- Sponsor
- Universitas Indonesia
- Start
- Jul 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Nigella sativa seeds extract ointment in hypertension (HTN) (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Systolic Blood Pressure at 4 weeks. Status: unknown.
02
Drugs
Nigella sativa seeds extract ointment
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01393054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393054.